122 related articles for article (PubMed ID: 3119210)
1. Ifosfamide/mesna and hematuria.
Pratt CB; Goren MP
Cancer Treat Rep; 1987 Nov; 71(11):1124-5. PubMed ID: 3119210
[No Abstract] [Full Text] [Related]
2. Ifosfamide, mesna, and encephalopathy.
Lancet; 1985 Jun; 1(8442):1398-9. PubMed ID: 2861351
[No Abstract] [Full Text] [Related]
3. Irreversible encephalopathy with ifosfamide/mesna.
Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
[No Abstract] [Full Text] [Related]
4. Cyclophosphamide and ifosfamide: role of uroprotective agents.
Williams SD; Munshi N; Einhorn LH; Loehrer PJ
Cancer Invest; 1990; 8(2):269. PubMed ID: 2119246
[No Abstract] [Full Text] [Related]
5. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide/mesna encephalopathy.
McCallum AK
Lancet; 1987 Apr; 1(8539):987. PubMed ID: 2882385
[No Abstract] [Full Text] [Related]
7. Encephalopathy associated with ifosphamide/mesna therapy.
Meanwell CA; Blake AE; Latief TN; Blackledge G; Mould JJ; Blake DR; Shaw IC; Honigsberger L; Spooner D; Williams AC
Lancet; 1985 Feb; 1(8425):406-7. PubMed ID: 2857462
[No Abstract] [Full Text] [Related]
8. Prediction of ifosfamide/mesna associated encephalopathy.
Meanwell CA; Blake AE; Kelly KA; Honigsberger L; Blackledge G
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):815-9. PubMed ID: 3095121
[TBL] [Abstract][Full Text] [Related]
9. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
Steger GG; Dittrich C; Schlappack O; Mader R; Herold C; Brade WP; Keller A; Moser K
J Cancer Res Clin Oncol; 1988; 114(6):602-4. PubMed ID: 3144554
[TBL] [Abstract][Full Text] [Related]
10. Full-dose ifosfamide can be safely administered to outpatients.
Meazza C; Bisogno G; Casanova M; Zanetti I; Carli M; Ferrari A
Pediatr Blood Cancer; 2008 Feb; 50(2):375-8. PubMed ID: 16847930
[TBL] [Abstract][Full Text] [Related]
11. Severe renal failure following high-dose ifosfamide and mesna.
Willemse PH; de Jong PE; Elema JD; Mulder NH
Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
Burkert H; Schnitker J; Fichtner E
MMW Munch Med Wochenschr; 1979 Jun; 121(22):760-2. PubMed ID: 112422
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
Ghosn M; Carde P; Leclerq B; Flamant F; Friedman S; Droz JP; Hayat M
Bull Cancer; 1988; 75(4):391-2. PubMed ID: 3132998
[TBL] [Abstract][Full Text] [Related]
14. CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas.
Delépine N; Taillard F; Desbois JG; Cornille H; Delépine G; Jasmin C
Biomed Pharmacother; 1986; 40(5):173-5. PubMed ID: 3098318
[TBL] [Abstract][Full Text] [Related]
15. [Encephalopathy caused by an ifosfamide-mesna combination].
Beuzeboc P; Dorval T; Garcia-Giralt E; Jouve M; Livartowski A; Palangie T; Scholl S; Pouillart P
Presse Med; 1988 Apr; 17(12):591-2. PubMed ID: 2967486
[No Abstract] [Full Text] [Related]
16. [Epileptic seizures and treatment with ifosfamide-mesna].
Somma-Mauvais H; Farisse P; Viallat JR
Rev Neurol (Paris); 1994; 150(4):307-8. PubMed ID: 7863185
[TBL] [Abstract][Full Text] [Related]
17. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
Husband DJ; Watkin SW
Lancet; 1988 May; 1(8594):1116. PubMed ID: 2896952
[No Abstract] [Full Text] [Related]
18. Fatal encephalopathy with ifosfamide/mesna.
Verdeguer A; Castel V; Esquembre C; Ferris J; Fernandez JM; Ruiz JG
Pediatr Hematol Oncol; 1989; 6(4):383-5. PubMed ID: 2518327
[No Abstract] [Full Text] [Related]
19. Continuously improving ifosfamide/mesna: a winning combination.
Anderson P
Pediatr Blood Cancer; 2010 Oct; 55(4):599-600. PubMed ID: 20589648
[No Abstract] [Full Text] [Related]
20. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
